Utama › Penyakit Buah Pinggang Kronik › Utah
Kajian klinikal Penyakit Buah Pinggang Kronik di Utah
7 kajian untuk Penyakit Buah Pinggang Kronik sedang mencari peserta di lokasi di Utah.
Bandar di Utah
Teks kajian rasmi (Bahasa Inggeris)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Ogden Clinic - Canyon View, Ogden
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07783802A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, South Salt Lake
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06742723A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
- Primary Children's Hospital, Salt Lake City
Mengambil pesertaFasa 3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07107945A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Research Site, South Salt Lake
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07753993Sit Less, Interact and Move More (SLIMM) 2 Study
- University of Utah, Salt Lake City
Mengambil pesertaFasa 2
Umur 20 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT05173714Study of BHV-1400 in IgA Nephropathy
- Site-016, Salt Lake City
Mengambil pesertaFasa 1
Umur 18 hingga 65 · Semua jantina · Dikemas kini 23 Jun 2026 · NCT07054684A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
- Primary Childrens Hospital Outpatient Services, Salt Lake City
Mengambil pesertaFasa 3
Umur 0 hingga 18 · Semua jantina · Dikemas kini 27 Feb 2026 · NCT03633708Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.